Dyslipidemia, statins, and CKD patients' outcomes - review of the evidence in the post-sharp era.

@article{Heymann2012DyslipidemiaSA,
  title={Dyslipidemia, statins, and CKD patients' outcomes - review of the evidence in the post-sharp era.},
  author={Eric P Heymann and Theodoros Ioannis Kassimatis and David J. A. Goldsmith},
  journal={Journal of nephrology},
  year={2012},
  volume={25 4},
  pages={460-72}
}
Hyperlipidemia in the general population is strongly associated with an increased incidence of major adverse cardiovascular (CV) events (MACE). It is well established that HMG-CoA reductase inhibitors (statins) reduce CV and all-cause mortality in the general population, as well as in patients with CV disease (CVD). However, such a finding has not been… CONTINUE READING